• Planned acquisition reinforces Sandoz strategic focus on Japan
  • Aspen portfolio in Japan consists primarily of off-patent branded medicines with focus on anesthetics and specialty brands
  • Medicines complement Sandoz broad hospital portfolio and pipeline in Japan thereby expanding access to the hospital channel

Holzkirchen, Germany, November 11, 2019 – Sandoz today announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated …

  • Planned acquisition reinforces Sandoz strategic focus on Japan
  • Aspen portfolio in Japan consists primarily of off-patent branded medicines with focus on anesthetics and specialty brands
  • Medicines complement Sandoz broad hospital portfolio and pipeline in Japan thereby expanding access to the hospital channel

Holzkirchen, Germany, November 11, 2019 – Sandoz today announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated …